DGSIX
Price
$20.66
Change
+$0.04 (+0.19%)
Updated
Apr 25 closing price
Net Assets
3.46B
RLBEX
Price
$33.77
Change
+$0.13 (+0.39%)
Updated
Apr 25 closing price
Net Assets
230.79B
Ad is loading...

DGSIX vs RLBEX

Header iconDGSIX vs RLBEX Comparison
Open Charts DGSIX vs RLBEXBanner chart's image
DFA Global Allocation 60/40 I
Price$20.66
Change+$0.04 (+0.19%)
VolumeN/A
Net Assets3.46B
American Funds American Balanced R4
Price$33.77
Change+$0.13 (+0.39%)
VolumeN/A
Net Assets230.79B
DGSIX vs RLBEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DGSIX vs. RLBEX commentary
Apr 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DGSIX is a Hold and RLBEX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 231B vs. DGSIX (3.46B). DGSIX pays higher dividends than RLBEX: DGSIX (2.68) vs RLBEX (1.97). DGSIX was incepted earlier than RLBEX: DGSIX (21 years) vs RLBEX (23 years). RLBEX (0.60) is less costly to investors than DGSIX (0.42). DGSIX has a lower initial minimum investment than RLBEX: DGSIX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 4.87 vs. DGSIX (2.57). RLBEX return over 5 years is better than : 36.26 vs. DGSIX (33.73).
DGSIXRLBEXDGSIX / RLBEX
Total Expense Ratio0.250.6042%
Annual Report Gross Expense Ratio0.420.6070%
Fund Existence21 years23 years-
Gain YTD-1.019-1.15688%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.46B231B1%
Annual Yield % from dividends2.681.97136%
Returns for 1 year2.574.8753%
Returns for 3 years9.1916.4656%
Returns for 5 years33.7336.2693%
Returns for 10 years46.7849.3995%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XAGE0.16N/A
+2.63%
Longevity Health Holdings Inc
VMEO5.200.06
+1.17%
Vimeo
NBIX106.730.97
+0.92%
Neurocrine Biosciences
EVO4.220.01
+0.24%
Evotec SE
CNF0.66N/A
+0.02%
CNFinance Holdings Limited